---
title: "NMSC Immunotherapy Guide IAR - Reviews, Revenue and Downloads in Italy | Apple App Store"
description: "In nonmelanoma skin cancer (NMSC), particularly cutaneous squamous cell carcinoma (cSCC), treatment selection has evolved with the integration of immune checkpoint inhibitors (ICIs) across multiple st"
---

# NMSC Immunotherapy Guide IAR — Italy

![NMSC Immunotherapy Guide IAR App Icon](https://is1-ssl.mzstatic.com/image/thumb/Purple211/v4/3d/e3/87/3de38732-08c3-e60a-d6a5-56013e3a5a42/AppIcon-0-0-1x_U007emarketing-0-8-0-85-220.png/434x0w.png)

**Developer:** [Unknown](https://apptail.io/developer/unknown-tkZ)
**Category:** Medical
**Rating:** N/A (0 ratings)
**Price:** Free
**Bundle ID:** com.mlg.nmsciar
**Store:** Apple App Store
**Country:** Italy
**Version:** 1.0 (released 2026-05-28)
**Original Release:** 2026-05-28
**Languages:** English

**App Store Link:** [Download on Apple App Store](https://apps.apple.com/it/app/app/id6771424147)
**AppTail Page:** [https://apptail.io/app/nmsc-immunotherapy-guide-iar-lDhA/italy](https://apptail.io/app/nmsc-immunotherapy-guide-iar-lDhA/italy)

## NMSC Immunotherapy Guide IAR Description
In nonmelanoma skin cancer (NMSC), particularly cutaneous squamous cell carcinoma (cSCC), treatment selection has evolved with the integration of immune checkpoint inhibitors (ICIs) across multiple stages of disease. Current guidelines support a risk-adapted approach in which ICIs play a central role for patients with high-risk, locally advanced, or metastatic disease, as well as an emerging role in earlier treatment settings.

For unresectable or metastatic disease, ICIs targeting the PD-1/PD-L1 pathway are the preferred systemic therapy, offering durable responses and a favorable tolerability profile compared with traditional approaches. Their use is supported by the underlying tumor biology of cSCC, which is characterized by a high tumor mutational burden driven by ultraviolet radiation exposure. This leads to increased neoantigen formation and enhanced tumor immunogenicity, making these tumors particularly responsive to immune modulation. In addition, upregulation of immune checkpoint pathways such as PD-1/PD-L1 contributes to immune evasion, providing a strong mechanistic rationale for checkpoint blockade.

Beyond advanced disease, ICIs are increasingly being incorporated into neoadjuvant and adjuvant treatment strategies for high-risk, resectable NMSC. In the neoadjuvant setting, ICIs may reduce tumor burden, improve surgical outcomes, and, in some cases, enable less extensive resections. In the adjuvant setting, they are being explored to reduce the risk of recurrence following surgery, particularly in patients with high-risk pathologic features. These approaches reflect a shift toward earlier immune intervention in the disease course.

## NMSC Immunotherapy Guide IAR Screenshots
- [Screenshot 1](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/35/a0/63/35a06336-b50d-708f-faa6-dd26e716e798/iPhone-6-5_iPhone_6.5_013_0000.png/2778x1284.png)
- [Screenshot 2](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/2b/e8/de/2be8de76-f1c3-2d81-632b-df84588f39e1/iPhone-6-5_iPhone_6.5_016_0000.png/2778x1284.png)
- [Screenshot 3](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/21/a1/ac/21a1ac0f-ac30-0b5b-0455-26c86c31e177/iPhone-6-5_iPhone_6.5_015_0000.png/2778x1284.png)







## NMSC Immunotherapy Guide IAR Available In
- [France](https://apptail.io/app/nmsc-immunotherapy-guide-iar-lDhA/france)
- [United Kingdom](https://apptail.io/app/nmsc-immunotherapy-guide-iar-lDhA/united-kingdom)
- [Italy](https://apptail.io/app/nmsc-immunotherapy-guide-iar-lDhA/italy)
- [Japan](https://apptail.io/app/nmsc-immunotherapy-guide-iar-lDhA/japan)
- [Vietnam](https://apptail.io/app/nmsc-immunotherapy-guide-iar-lDhA/vietnam)

---

## About AppTail

[AppTail](https://apptail.io) is a mobile app intelligence platform providing app analytics, ASO (App Store Optimization) tools, keyword tracking, competitor analysis, revenue estimates, and review monitoring for iOS App Store apps. Track your app's performance, discover ranking keywords, monitor competitors, and analyze market trends.

- [Search Apps](https://apptail.io)
- [Top Charts](https://apptail.io/top-iphone-apps)
- [Sign Up for Full Access](https://app.apptail.io/signup?utm_campaign=ai-crawl&utm_content=footer)

*Data provided by [AppTail](https://apptail.io) - Mobile App Intelligence Platform*